A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
Pfizer
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Pfizer
Hutchmed
Mirati Therapeutics Inc.
Jiangsu Famous Medical Technology Co., Ltd.
Isofol Medical AB
Amgen
Health Clinics Limited
Novartis
Norgine
Amgen
INSYS Therapeutics Inc
Monsea Ltd.
Braintree Laboratories
Braintree Laboratories
Pfizer
Novartis
Sanofi
Mast Therapeutics, Inc.